Features of Risk Stratification, Diagnosis and Secondary Prevention in Patients with Multifocal Arterial Disease. Part 2: Treatment Options
Open Access
- 7 May 2021
- journal article
- research article
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 17 (2), 239-248
- https://doi.org/10.20996/1819-6446-2021-03-02
Abstract
The similarity of the pathogenesis of atherosclerosis and atherothrombotic complications, regardless of their location, makes the approaches to secondary prevention similar, which include lifestyle modification, pharmacotherapy of hemodynamic disorders, metabolic changes and hemostasis. Secondary prophylaxis in patients with multifocal arterial lesions using antihypertensive, antithrombotic and lipid-lowering therapy provides a more pronounced decrease in the incidence of cardiovascular complications than in lesions of single vascular lesions due to a higher initial risk. However, these treatments do not reduce the risk to the level that is achieved by treating patients with less atherosclerotic lesion. In this regard, it is of interest to use the currently available new methods and regimens of drug therapy in patients with multifocal arterial lesions, which make it possible to more intensively influence the mechanisms of atherosclerosis progression and more effectively prevent the development of its complications.Keywords
This publication has 54 references indexed in Scilit:
- Accelerated In Vivo Thrombin Formation Independently Predicts the Presence and Severity of CT Angiographic Coronary AtherosclerosisJACC: Cardiovascular Imaging, 2012
- Rivaroxaban in Patients with a Recent Acute Coronary SyndromeThe New England Journal of Medicine, 2012
- Apixaban with Antiplatelet Therapy after Acute Coronary SyndromeThe New England Journal of Medicine, 2011
- Outcomes Among Hypertensive Patients With Concomitant Peripheral and Coronary Artery DiseaseHypertension, 2010
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular EventsThe New England Journal of Medicine, 2008
- Post‐coronary intervention recurrent ischemia in the presence of adequate platelet inhibition by dual antiplatelet therapy: what are we overlooking?Journal of Thrombosis and Haemostasis, 2007
- Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA TrialJournal of Invasive Cardiology, 2007
- Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic EventsThe New England Journal of Medicine, 2006
- Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25 307 patientsEuropean Heart Journal, 2005
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996